Present and future of Al, open science, and transparency in regulatory science

At the 13th Global Summit on Regulatory Science (GSRS23), a pre-summit workshop organized by EBTC and EFSA explored the integration of artificial intelligence (AI), big data, and new approach methodologies (NAMs) into regulatory science. Experts Presentations highlighted how AI can enhance toxicological assessments by improving data processing, enabling predictive modeling, and supporting systematic evidence synthesis. Emphasis was placed on the need for high-quality, interoperable data and FAIR principles to ensure reliable AI outputs. Case studies, such as the ONTOX project, demonstrated practical progress toward animal-free, AI-supported toxicity prediction. Key challenges discussed included data quality and data gaps, legal and ethical considerations, and the need for trust building, standards, and the regulatory readiness for AI. The workshop concluded that while AI holds transformative promise, responsible implementation requires coordinated efforts across science, policy, and regulation.

Authors

Institutions

Publication Details

Journal
Evidence-Based Toxicology
Published
2025-06-30
DOI
https://doi.org/10.1080/2833373x.2025.2520764
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Present and future of Al, open science, and transparency in regulatory science

Katya Tsaioun, Mathieu Vinken, Sebastian Hoffmann, Ákos Jóźwiak et al.
Evidence-Based Toxicology
Ethics in Clinical Research
article

Present and future of Al, open science, and transparency in regulatory science

Katya Tsaioun, Mathieu Vinken, Sebastian Hoffmann, Ákos Jóźwiak, Thomas Härtung
article en

Abstract

At the 13th Global Summit on Regulatory Science (GSRS23), a pre-summit workshop organized by EBTC and EFSA explored the integration of artificial intelligence (AI), big data, and new approach methodologies (NAMs) into regulatory science. Experts Presentations highlighted how AI can enhance toxicological assessments by improving data processing, enabling predictive modeling, and supporting systematic evidence synthesis. Emphasis was placed on the need for high-quality, interoperable data and FAIR principles to ensure reliable AI outputs. Case studies, such as the ONTOX project, demonstrated practical progress toward animal-free, AI-supported toxicity prediction. Key challenges discussed included data quality and data gaps, legal and ethical considerations, and the need for trust building, standards, and the regulatory readiness for AI. The workshop concluded that while AI holds transformative promise, responsible implementation requires coordinated efforts across science, policy, and regulation.

Evidence-Based ToxicologyVol. 3(1)
Bloomberg (United States) (US), Vrije Universiteit Brussel (BE), University of Veterinary Medicine (HU), BH Consulting (Ireland) (IE), Pharmac (NZ), Syreon Research Institute (Hungary) (HU)
Openalex Percentile: Top 78%
Ethics in Clinical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Present and future of Al, open science, and transparency in regulatory science — Katya Tsaioun, Mathieu Vinken, et al. · Evidence-Based Toxicology (2025) | TGRS Research Map | TGRS